- Home
- LUNG vs IIF Comparison
LUNG vs IIF Comparison
Compare LUNG & IIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- IIF
- Stock Information
- Founded
- LUNG 1995
- IIF 1993
- Country
- LUNG United States
- IIF United States
- Employees
- LUNG N/A
- IIF N/A
- Industry
- LUNG Industrial Specialties
- IIF Trusts Except Educational Religious and Charitable
- Sector
- LUNG Health Care
- IIF Finance
- Exchange
- LUNG Nasdaq
- IIF Nasdaq
- Market Cap
- LUNG 256.3M
- IIF 248.2M
- IPO Year
- LUNG 2020
- IIF N/A
- Fundamental
- Price
- LUNG $6.36
- IIF $24.42
- Analyst Decision
- LUNG Buy
- IIF
- Analyst Count
- LUNG 6
- IIF 0
- Target Price
- LUNG $11.92
- IIF N/A
- AVG Volume (30 Days)
- LUNG 214.3K
- IIF 45.4K
- Earning Date
- LUNG 02-19-2025
- IIF 01-01-0001
- Dividend Yield
- LUNG N/A
- IIF 13.94%
- EPS Growth
- LUNG N/A
- IIF N/A
- EPS
- LUNG N/A
- IIF N/A
- Revenue
- LUNG $79,302,000.00
- IIF N/A
- Revenue This Year
- LUNG $22.26
- IIF N/A
- Revenue Next Year
- LUNG $18.72
- IIF N/A
- P/E Ratio
- LUNG N/A
- IIF N/A
- Revenue Growth
- LUNG 22.34
- IIF N/A
- 52 Week Low
- LUNG $5.46
- IIF $18.95
- 52 Week High
- LUNG $14.84
- IIF $24.41
- Technical
- Relative Strength Index (RSI)
- LUNG 41.35
- IIF 26.98
- Support Level
- LUNG $6.24
- IIF $24.31
- Resistance Level
- LUNG $7.27
- IIF $24.87
- Average True Range (ATR)
- LUNG 0.39
- IIF 0.30
- MACD
- LUNG -0.06
- IIF 0.02
- Stochastic Oscillator
- LUNG 2.52
- IIF 3.31
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About IIF Morgan Stanley India Investment Fund Inc.
Morgan Stanley India Investment Fund, Inc. is the United States based non-diversified, closed-end management investment company. Its investment objective is to achieve long-term capital appreciation through investments in equity securities of Indian Issuers. The company's portfolio of investments consists of the investment in different sectors such as auto components, banks, capital markets, construction and engineering, pharmaceuticals and others.